AlphaYouMD
Insider selling
Mittie Doyle sold $14K of Avalo Therapeutics, Inc. (AVTX) stock
Mittie Doyle, Chief Medical Officer of Avalo Therapeutics, Inc. (AVTX), sold 679 shares of AVTX stock worth $14K, per an SEC Form 4 filed Sep 1, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Aug 28, 2026, 4 days before it was made public.
AVTX has moved -15.4% since the trade date, from $19.59 to $16.57 (Sep 18, 2026 close).
- Traded
- Aug 28, 2026
- Disclosed
- Sep 1, 2026
- Filing delay
- 4 days
- Price since
- -15.4%
- Role
- Chief Medical Officer
- Source
- SEC Form 4
More AVTX insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.